ScoreWhy is Corona Remedies Ltd ?
1
High Management Efficiency with a high ROCE of 0%
2
The company is Net-Debt Free
3
Healthy long term growth as Operating profit has grown by an annual rate 0%
4
Flat results in Mar 26
- PBT LESS OI(Q) At Rs 50.63 cr has Fallen at -15.8% (vs previous 4Q average)
5
With ROCE of 29.5, it has a Very Expensive valuation with a 12.4 Enterprise value to Capital Employed
- Over the past year, while the stock has generated a return of NA, its profits have risen by 34%
6
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 0.66% over the previous quarter and collectively hold 9.26% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Corona Remedies should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
27.90
Debt to EBITDA (avg)
0.56
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.54
Tax Ratio
23.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.26%
ROCE (avg)
29.49%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
53
Industry P/E
34
Price to Book Value
14.19
EV to EBIT
41.90
EV to EBITDA
36.49
EV to Capital Employed
12.36
EV to Sales
7.63
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
29.49%
ROE (Latest)
26.75%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Mildly Bearish
OBV
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
PAT(Latest six months)
At Rs 100.88 cr has Grown at 31.87%
-2What is not working for the Company
PBT LESS OI(Q)
At Rs 50.63 cr has Fallen at -15.8% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Corona Remedies
Profit After Tax (PAT) - Latest six months
At Rs 100.88 cr has Grown at 31.87%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Corona Remedies
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 50.63 cr has Fallen at -15.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 60.11 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
Highest at Rs 4.11 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
